These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

418 related items for PubMed ID: 17269263

  • 1. Should we limit the ferritin upper threshold to 500 ng/ml in CKD patients?
    Dukkipati R, Kalantar-Zadeh K.
    Nephrol News Issues; 2007 Jan; 21(1):34-8. PubMed ID: 17269263
    [Abstract] [Full Text] [Related]

  • 2. Upper limit of serum ferritin: misinterpretation of the 2006 KDOQI anemia guidelines.
    Fishbane S.
    Semin Dial; 2008 Jan; 21(3):217-20. PubMed ID: 18248518
    [Abstract] [Full Text] [Related]

  • 3. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y, Nishi S, Akiba T, Hirakata H, Iseki K, Kubota M, Kuriyama S, Komatsu Y, Suzuki M, Nakai S, Hattori M, Babazono T, Hiramatsu M, Yamamoto H, Bessho M, Akizawa T.
    Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
    [Abstract] [Full Text] [Related]

  • 4. Intravenous iron versus erythropoiesis-stimulating agents: friends or foes in treating chronic kidney disease anemia?
    Kalantar-Zadeh K, Streja E, Miller JE, Nissenson AR.
    Adv Chronic Kidney Dis; 2009 Mar; 16(2):143-51. PubMed ID: 19233073
    [Abstract] [Full Text] [Related]

  • 5. Maintaining higher TSATs and other iron indices is beneficial in management of anemic hemodialysis patients.
    Besarab A, Dalton CL.
    Nephrol Nurs J; 2001 Aug; 28(4):429-34. PubMed ID: 12143465
    [Abstract] [Full Text] [Related]

  • 6. Monitoring iron status in end-stage renal disease patients on hemodialysis.
    Rafi A, Karkar A, Abdelrahman M.
    Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):73-8. PubMed ID: 17237895
    [Abstract] [Full Text] [Related]

  • 7. The fascinating but deceptive ferritin: to measure it or not to measure it in chronic kidney disease?
    Kalantar-Zadeh K, Kalantar-Zadeh K, Lee GH.
    Clin J Am Soc Nephrol; 2006 Sep; 1 Suppl 1():S9-18. PubMed ID: 17699375
    [Abstract] [Full Text] [Related]

  • 8. Intravenous iron in chronic kidney disease: haemoglobin change shortly after treatment of patients neither on dialysis nor on erythropoietin.
    Tagboto S, Cropper L, Mostafa S, Turner J, Bailey G, Pugh-Clarke K.
    J Ren Care; 2008 Sep; 34(3):112-5. PubMed ID: 18786076
    [Abstract] [Full Text] [Related]

  • 9. The challenges of using serum ferritin to guide i.v. iron treatment practices in patients on hemodialysis with anemia.
    Easom A.
    Nephrol Nurs J; 2006 Sep; 33(5):543-51; quiz 552-3. PubMed ID: 17044438
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Updating practices in an evolving IV iron and anemia environment: practical solutions.
    Amerling R, Easom A, Juergensen P.
    Nephrol Nurs J; 2007 Sep; 34(5):533-41; quiz 542-3. PubMed ID: 18041456
    [Abstract] [Full Text] [Related]

  • 12. Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients.
    Chen YC, Hung SC, Tarng DC.
    Am J Kidney Dis; 2006 Jun; 47(6):1036-44. PubMed ID: 16731299
    [Abstract] [Full Text] [Related]

  • 13. Serum ferritin in chronic kidney disease: reconsidering the upper limit for iron treatment.
    Fishbane S, Kalantar-Zadeh K, Nissenson AR.
    Semin Dial; 2004 Jun; 17(5):336-41. PubMed ID: 15461737
    [Abstract] [Full Text] [Related]

  • 14. Assessing iron status: beyond serum ferritin and transferrin saturation.
    Wish JB.
    Clin J Am Soc Nephrol; 2006 Sep; 1 Suppl 1():S4-8. PubMed ID: 17699374
    [Abstract] [Full Text] [Related]

  • 15. Iron indices in chronic kidney disease in the National Health and Nutritional Examination Survey 1988-2004.
    Fishbane S, Pollack S, Feldman HI, Joffe MM.
    Clin J Am Soc Nephrol; 2009 Jan; 4(1):57-61. PubMed ID: 18987297
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.
    Attallah N, Osman-Malik Y, Frinak S, Besarab A.
    Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942
    [Abstract] [Full Text] [Related]

  • 19. The Gulf Survey on Anemia Management (GSAM 2005).
    Alsuwaida A, Abdulkareem A, Alwakeel J.
    Saudi J Kidney Dis Transpl; 2007 Jun; 18(2):206-14. PubMed ID: 17496396
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.